Business News

The FDA approves the Pfizer vaccine in opposition to Covid-19 within the US

This Friday, the U.S. Food and Drug Administration approved the use of pharmaceutical company Pfizer's coronavirus vaccine.

Grow your business, Not your inbox

Stay up to date and subscribe to our daily newsletter now!

December
12, 2020

2 min read

This article has been translated from our Spanish edition using AI technologies. Errors can occur due to this process.

That Friday night, the FDA's approval was signed, hours after White House Chief of Staff Mark Meadows alerted Stephen Hahn, the agency's director, to prepare it for the same day.

It did so some time after the Federal Commission for Protection from Health Risks (Cofepris) approved the emergency use of the Pfizer and BioNTech vaccine for coronavirus prevention. The FDA approved the same vaccine for your country.

According to the New York Times, about 2.9 million doses of the vaccine will be shipped to the United States the following week after approval.

Pfizer has pledged to have 25 million vaccines with them by the end of the year – two doses are required for each immunization – and 100 million by March.

The decision made will make the United States the sixth country to approve the vaccine, alongside the United Kingdom, Bahrain, Canada, Saudi Arabia and Mexico. Further approvals are expected in a few weeks, also from the European Union.

The Pfizer vaccine comes at a critical time in the US, there are roughly 200,000 infections a day and this week there has been an average of 3,000 deaths in a 24 hour period.

The Centers for Disease Control and Prevention recommend that the first doses are for health workers and people who live or work in facilities designated for long-term medical care, such as medical care workers. B. for retirement homes or centers with people with disabilities. Disability.

To Know More: Last Minute: Mexico Approves Pfizer's Vaccine Against COVID-19

Related Articles